Literature DB >> 8465732

Immediate and long-term results of balloon and surgical closed mitral valvotomy: a randomized comparative study.

R Arora1, M Nair, G S Kalra, M Nigam, M Khalilullah.   

Abstract

Balloon mitral valvotomy (BMV) constitutes an important alternative to surgical closed mitral valvotomy (CMV) for the treatment of rheumatic mitral stenosis. To compare the immediate and long-term results of these procedures, 200 patients with rheumatic mitral stenosis were randomly assigned to undergo either BMV (n = 100) or CMV (n = 100). The age range was 10 to 30 (mean 19.4 +/- 6.5) years. Both procedures resulted in significant and similar increases in mitral valve area (BMV: 0.85 +/- 0.26 to 2.39 +/- 0.94 cm2; CMV: 0.79 +/- 0.21 to 2.2 +/- 0.85 cm2; p = NS). Mitral regurgitation developed in 14 patients after BMV and in 12 patients after CMV. Eighty patients in each group have now been followed for a mean period of 22 +/- 6.3 (range 6 to 38) months by repeat echocardiographic study. Restenosis (defined as a loss of more than 50% of the achieved increase in mitral valve area) was seen in four (5%) patients after BMV and in three (4%) after CMV. Symptomatic restenosis was seen in only one patient who at follow-up examination 20 months after CMV had a mitral valve area of 0.8 cm2 and underwent successful balloon valvotomy. We conclude that the immediate and long-term results obtained with percutaneous BMV and surgical closed mitral commissurotomy are comparable.

Entities:  

Mesh:

Year:  1993        PMID: 8465732     DOI: 10.1016/0002-8703(93)90118-s

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  13 in total

Review 1.  Percutaneous mitral balloon valvuloplasty.

Authors:  C E Mayes; J E Cigarroa; R A Lange; L D Hillis
Journal:  Clin Cardiol       Date:  1999-08       Impact factor: 2.882

2.  Long term outcome of percutaneous mitral balloon valvotomy in patients aged 70 and over.

Authors:  N Sutaria; A T Elder; T R Shaw
Journal:  Heart       Date:  2000-04       Impact factor: 5.994

3.  A differentiated morphological parameter-coding system to describe the suitability of mitral valve stenoses intended for percutaneous valvotomy.

Authors:  Nikola Bogunovic; Dieter Horstkotte; Werner Scholtz; Lothar Faber; Lukas Bogunovic; Frank van Buuren
Journal:  Heart Vessels       Date:  2014-06-27       Impact factor: 2.037

4.  Mitral balloon valvuloplasty.

Authors:  Mohamed Eid Fawzy
Journal:  J Saudi Heart Assoc       Date:  2010-05-11

5.  Predictors of event-free survival after percutaneous mitral commissurotomy.

Authors:  N Meneveau; F Schiele; M F Seronde; V Breton; S Gupta; Y Bernard; J P Bassand
Journal:  Heart       Date:  1998-10       Impact factor: 5.994

Review 6.  [Diagnosis and differential therapy of mitral stenosis].

Authors:  D Fassbender; H K Schmidt; H Seggewiss; H Mannebach; N Bogunovic
Journal:  Herz       Date:  1998-11       Impact factor: 1.443

7.  Clinical and haemodynamic profiles of young, middle aged, and elderly patients with mitral stenosis undergoing mitral balloon valvotomy.

Authors:  T R D Shaw; N Sutaria; B Prendergast
Journal:  Heart       Date:  2003-12       Impact factor: 5.994

8.  Study on the long-term curative effect of repeat percutaneous balloon mitral valvuloplasty in patients with mitral restenosis.

Authors:  Ling Zhang; Jiliu Hou; Yulong Duan; Junjun Chen; Huijuan Du; Zhengang Shi
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

9.  Percutaneous Balloon Mitral Valvuloplasty and Early Right Atrial Clot Formation: A Case Report.

Authors:  Rezvaniyeh Salehi; Naser Aslan Abadi; Razieh Parizad; Sanam Mirzayi; Elnaz Javanshir
Journal:  J Tehran Heart Cent       Date:  2020-04

10.  Left Ventricular Remodeling Following Balloon Mitral Valvuloplasty in Rheumatic Mitral Stenosis: Magnetic Resonance Imaging Study.

Authors:  Amir Anwar Samaan; Karim Said; Wafaa El Aroussy; Mohammed Hassan; Soha Romeih; Amr El Sawy; Mohammed Eid Fawzy; Magdi Yacoub
Journal:  Front Cardiovasc Med       Date:  2021-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.